The present invention is directed to compounds which are inhibitors of the dipeptidyl peptidase-IV enzyme ("DP-IV inhibitors") and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.

 
Web www.patentalert.com

< Benzothiazepine derivatives for the treatment of hyperlipidemia

< Polycyclic compounds which modulate PPAR.gamma. type receptors and cosmetic/pharmaceutical compositions comprised thereof

> Substituted pyrroline kinase inhibitors

> Corticotropin releasing factor antagonists
~ 00297